Skip to content

QualityPoint Technologies News

Emerging Technologies News

Menu
  • About Us
  • Technology
  • Medical
  • Robots
  • Artificial Intelligence (AI)
  • 3D Printing
  • Contact Us
Menu

Huge Discount Offer: 14 ebooks + 2 courses

Global CRISPR/Cas9 Market will Cross US$ 1.5 Billion by 2022

Posted on October 21, 2016

The advent of CRISPR/Cas9 has revolutionized the Genome Editing Industry. This technique is allowing a previously unattainable level of genomic targeting with greater efficiency and simplicity. Due to this ability, the share of CRISPR/Cas9 is continuously increasing in the Genome Editing Industry.

According to the “Global CRISPR/Cas9 Market Outlook 2022” report provided by Research and Markets, it is anticipated that the global CRISPR/Cas9 market will cross US $1.5 Billion by 2022.

The growth of the market is likely to be driven by expanding drug discovery applications and increasing research related activities for exploring CRISPR/Cas9 therapeutic applications.

The report, Global CRISPR/Cas9 Market Outlook 2022, provides an insight into the current and future prospective of this market. This report covers the major opportunities in this area, and drivers that have impact on the market. The report also discusses some of the challenges currently faced by the market.

The major application areas of CRISPR/Cas9 include cell line engineering, genetic engineering, CRISPR plasmid development, human stem cells, gene library development and producing GM organisms or crops. Cell Line Engineering is the largest area of application of CRISPR/Cas9, followed by Genetic Engineering. This large share can be attributed to extensibility and multiplexity of CRISPR/Cas9 in modifying the multiple sites within the mammalian genome. The genetic engineering market employing CRISPR/Cas9 is expected to witness the highest growth in 2016-2022. This growth is likely to be driven by reduction of evolutionary time in comparison to previous gene editing tools, such as Zinc Finger Nucleases (ZFNs) and Transcription Activator-Like Effector Nucleases (TALENs).

Share

Related News:

  1. Smart Glasses can automatically adjust the focus on what a person is seeing
  2. New app uses smartphone selfies to screen for pancreatic cancer
  3. Use of Prosthetic Hands becomes Easier with New Technology
  4. 3d Printing in the Medical field
Master RAG ⭐ Rajamanickam.com ⭐ Bundle Offer ⭐ Merch ⭐ AI Course

  • Bundle Offer
  • Hire AI Developer

Latest News

  • ​Firebase Studio: Google’s New Platform for Building AI-Powered Applications April 11, 2025
  • MIT Researchers Develop Framework to Enhance LLMs in Complex Planning April 7, 2025
  • MIT and NVIDIA Unveil HART: A Breakthrough in AI Image Generation March 25, 2025
  • Can LLMs Truly Understand Time Series Anomalies? March 18, 2025
  • Can AI tell us if those Zoom calls are flowing smoothly? March 11, 2025
  • New AI Agent, Manus, Emerges to Bridge the Gap Between Conception and Execution March 10, 2025
  • OpenAI Unveils GPT-4.5, Promising Enhanced AI Performance February 28, 2025
  • Anthropic Launches Claude Code to Revolutionize Developer Productivity February 25, 2025
  • Google Unveils Revolutionary AI Co-Scientist! February 24, 2025
  • Microsoft’s Majorana 1 Chip: Revolutionizing Quantum Computing with Topological Core Architecture February 20, 2025

Pages

  • About Us
  • Basics of 3D Printing
  • Key Innovations
  • Know about Graphene
  • Privacy Policy
  • Shop
  • Contact Us

Archives

Developed by QualityPoint Technologies (QPT)

QPT Products | eBook | Privacy

Timesheet | Calendar Generator

©2025 QualityPoint Technologies News | Design: Newspaperly WordPress Theme
Menu
  • About Us
  • Technology
  • Medical
  • Robots
  • Artificial Intelligence (AI)
  • 3D Printing
  • Contact Us